WallStreetZenWallStreetZen

NASDAQ: TARS
Tarsus Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Tarsus Pharmaceuticals revenue was $295.52M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $102.7M, up 31.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TARS annual revenue was $183.0M, with 948.6% growth year-over-year.

TARS past revenue growth

How has TARS's revenue growth performed historically?

Company
254.45%
Industry
150.55%
Market
20.43%
TARS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TARS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TARS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TARS revenue history

Current Revenue
$295.5M
Current Earnings
-$92.0M
Current Profit Margin
-31.1%

Be the first to know when TARS announces revenue.

TARS Revenue History By Year

TARS Yearly RevenueTARS RevenueTARS ChangeTARS Revenue Growth
2024-12-31$182.95M$165.51M+948.62%
2023-12-31$17.45M-$8.37M-32.42%
2022-12-31$25.82M-$31.21M-54.73%
2021-12-31$57.03MN/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Tarsus Pharmaceuticals Revenue FAQ

What was TARS's revenue last quarter?

On Invalid Date, Tarsus Pharmaceuticals (NASDAQ: TARS) reported Q2 2025 revenue of $102.66 million up 151.54% year over year. In the same quarter last year, Tarsus Pharmaceuticals's revenue was $40.81 million.

What was Tarsus Pharmaceuticals's revenue in 2024?

Tarsus Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $182.95 million, a 948.62% increase year over year.

How much does Tarsus Pharmaceuticals make in a day?

Based on Tarsus Pharmaceuticals annual revenue for the past five years, TARS makes an average of $155,201.64 per day.

What was Tarsus Pharmaceuticals's annual revenue growth in the past year?

As of Q4 2025, Tarsus Pharmaceuticals's revenue has grown 254.45% year over year. This is 103.9 percentage points higher than the US Biotechnology industry revenue growth rate of 150.55%. Tarsus Pharmaceuticals's revenue in the past year totaled $295.52 million.

How much does Tarsus Pharmaceuticals make in a year?

Tarsus Pharmaceuticals's revenue by year for the past five years is:
  • Tarsus Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $182.95 million, a 948.62% increase year over year.
  • Tarsus Pharmaceuticals's annual revenue for Dec 31, 2023 was $17.45 million, a 32.42% decrease from 2022.
  • Tarsus Pharmaceuticals's annual revenue for 2022 was $25.82 million, a 54.73% decrease from 2021.
  • Tarsus Pharmaceuticals's annual revenue for 2021 was $57.03 million, a Infinity% increase from 2020.
  • Tarsus Pharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.